Novavax Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Novavax Inc inventory turnover ratio, the Novavax Inc 's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 7.67 in the first quarter 2026, yet the ratio remained below the average, as NVAX's market remain challenging.Average inventory processing period, for the Novavax Inc in Mar 31 2026 quarter, has decreased to 48 days, compare to 57 days, in the Dec 31 2025 quarter.

Within Healthcare sector 45 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 284, from total ranking in the fourth quarter 2025 at 457.

NVAX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Novavax Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NVAX Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	11.64 %	31.96 %	56.41 %	11.64 %	-34.95 %
Y / Y Cost of Sales Growth	117.46 %	-39.72 %	-64.54 %	-66.86 %	-76.16 %
Inventory Turnover Ratio (TTM)	7.67	6.41	8.19	13.38	17.13
NVAX's Total Ranking	# 284	# 457	# 279	# 233	# 133
Average inventory processing period	48	57	45	27	21
Seq. Inventory Growth	-0.75 %	-14.55 %	31.94 %	-0.22 %	17.3 %
Seq. Cost of Sales Growth	38.87 %	2.83 %	40.27 %	8.57 %	-61.51 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 2
Healthcare Sector	# 46
Overall Market	# 284

Inventory Turnover Ratio Statistics
High	Average	Low
19.15	11.36	6.41
(Dec 31 2024)		(Dec 31 2025)

NVAX Company Profile >> Back to NVAX Efficiency Comparisons >> Compare NVAX Inventory Turnover Ratio to its Competitors

Financial Statements
Novavax Inc 's Inventories	$ 11 Millions	Visit NVAX's Balance sheet
Novavax Inc 's Cost of Revenues TTM	$ 90 Millions	Visit NVAX's Income Statement
What are NVAX's Sales?		Visit NVAX's Sales by Segment

Other Inventory Turnover Ratios
Novavax Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
NVAX's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for NVAX's Competitors
Inventory Turnover Ratio for NVAX's Suppliers
Inventory Turnover Ratio for NVAX's Customers

You may also want to know
NVAX's Sales Growth Rates	NVAX's Pe Price to earnings ratio	NVAX's Receivables Turnover Ratio	NVAX's Stock Quote
NVAX's Net Income Growth Rates	NVAX's Ps Price to Sales ratio	NVAX's Sales per Employee	NVAX's Asset Turnover Ratio
NVAX's Net Margin	NVAX's Pb Price to Book ratio	NVAX's Financial Strength Ratios	NVAX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Teladoc Health Inc	20.90	$ 772.290 Millions	$ 37 Millions
Agape Atp Corporation	20.80	$ 0.667 Millions	$ 0 Millions
Labcorp Holdings Inc	19.53	$ 10,065.900 Millions	$ 516 Millions
Edap Tms Sa	19.36	$ 64.760 Millions	$ 3 Millions
Aspira Women s Health inc	19.29	$ 5.319 Millions	$ 0 Millions
Lucid Diagnostics Inc	18.30	$ 8.295 Millions	$ 0 Millions
Adapthealth Corp	17.66	$ 2,686.512 Millions	$ 152 Millions
Neuronetics Inc	17.04	$ 78.000 Millions	$ 5 Millions
Precipio inc	15.93	$ 14.540 Millions	$ 1 Millions
Rockwell Medical inc	15.34	$ 56.000 Millions	$ 4 Millions
Star Equity Holdings Inc	14.45	$ 112.008 Millions	$ 8 Millions
Aurinia Pharmaceuticals Inc	14.12	$ 30.596 Millions	$ 2 Millions
Natera Inc	13.48	$ 869.958 Millions	$ 65 Millions
Cryo cell International Inc	13.44	$ 7.049 Millions	$ 1 Millions
The Oncology Institute Inc	11.17	$ 211.805 Millions	$ 19 Millions
Genedx Holdings Corp	11.09	$ 135.000 Millions	$ 12 Millions
Infusystem Holdings Inc	10.96	$ 61.593 Millions	$ 6 Millions
Irhythm Holdings Inc	10.94	$ 228.000 Millions	$ 21 Millions
Earth Science Tech Inc	10.81	$ 8.224 Millions	$ 1 Millions
Option Care Health Inc	10.74	$ 4,579.720 Millions	$ 427 Millions
Zevra Therapeutics Inc	10.44	$ 17.034 Millions	$ 2 Millions
Alnylam Pharmaceuticals Inc	10.38	$ 814.503 Millions	$ 78 Millions
Nutriband Inc	10.06	$ 1.291 Millions	$ 0 Millions
Lantheus Holdings Inc	9.75	$ 610.000 Millions	$ 63 Millions
Sotera Health Company	9.58	$ 531.000 Millions	$ 55 Millions
Warby Parker Inc	9.23	$ 415.000 Millions	$ 45 Millions
National Vision Holdings Inc	8.90	$ 833.415 Millions	$ 94 Millions
Myriad Genetics Inc	8.35	$ 248.000 Millions	$ 30 Millions
Pulse Biosciences Inc	8.08	$ 0.909 Millions	$ 0 Millions
Castle Biosciences Inc	7.97	$ 75.178 Millions	$ 9 Millions

Date modified: 2026-08-30T14:38:12+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.